Home › Stock analysis › EW
Edwards Lifesciences (EW) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
EW rises 1.9% to $88.10. Closed at $88.10, +1.91% vs the prior close of $86.45. Day range $85.54–$88.41, opened at $86.62.
Last close$88.10+1.91%
Day range85.54–88.41
Open86.62
Volume4.68M
52-week range72.40–96.29
Avg volume (20d)3.78M
EW daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — EW rises 1.9% to $88.10
- Closed at $88.10, +1.91% vs the prior close of $86.45. Day range $85.54–$88.41, opened at $86.62.
- Volume was 4.68M shares, 1.4x its 50-day average of 3.28M.
- Price is -0.4% vs its 50-day average ($88.47) and +3.5% vs its 200-day average ($85.14).
- 52-week range $72.40–$96.29; today's close sits at 66% of that range, 8.5% below the 52-week high.
Oct 14, 2026 — EW rises 1.4% to $86.45
- Closed at $86.45, +1.38% vs the prior close of $85.27. Day range $84.83–$86.62, opened at $85.47.
- Volume was 4.04M shares, 1.2x its 50-day average of 3.28M.
- Price is -2.3% vs its 50-day average ($88.49) and +1.5% vs its 200-day average ($85.13).
- 52-week range $72.40–$96.29; today's close sits at 59% of that range, 10.2% below the 52-week high.
Oct 13, 2026 — EW dips 1.3% to $85.27
- Closed at $85.27, -1.30% vs the prior close of $86.39. Day range $85.07–$86.77, opened at $86.55.
- Volume was 3.64M shares, 1.1x its 50-day average of 3.29M.
- Price is -3.7% vs its 50-day average ($88.55) and +0.2% vs its 200-day average ($85.13).
- 52-week range $72.30–$96.29; today's close sits at 54% of that range, 11.4% below the 52-week high.
Oct 12, 2026 — EW rises 1.4% to $86.39
- Closed at $86.39, +1.38% vs the prior close of $85.21. Day range $84.55–$86.41, opened at $85.24.
- Volume was 3.32M shares, 1.0x its 50-day average of 3.30M.
- Price is -2.5% vs its 50-day average ($88.63) and +1.5% vs its 200-day average ($85.14).
- 52-week range $72.30–$96.29; today's close sits at 59% of that range, 10.3% below the 52-week high.
Oct 9, 2026 — EW rises 1.2% to $85.21
- Closed at $85.21, +1.15% vs the prior close of $84.24. Day range $83.22–$85.34, opened at $84.60.
- Volume was 3.89M shares, 1.2x its 50-day average of 3.30M.
- Price is -3.8% vs its 50-day average ($88.62) and +0.1% vs its 200-day average ($85.14).
- 52-week range $72.30–$96.29; today's close sits at 54% of that range, 11.5% below the 52-week high.
Oct 8, 2026 — EW dips 1.8% to $84.24, a 1-month low on 2.0x normal volume
- Closed at $84.24, -1.80% vs the prior close of $85.78. Day range $82.43–$85.78, opened at $85.65.
- Volume was 6.52M shares, 2.0x its 50-day average of 3.28M — unusually heavy trading.
- Price is -5.0% vs its 50-day average ($88.65) and -1.1% vs its 200-day average ($85.14).
- 52-week range $72.30–$96.29; today's close sits at 50% of that range, 12.5% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — EW dips 0.8% to $85.78
- Closed at $85.78, -0.81% vs the prior close of $86.48. Day range $85.49–$87.30, opened at $86.65.
- Volume was 3.51M shares, 1.1x its 50-day average of 3.33M.
- Price is -3.3% vs its 50-day average ($88.68) and +0.7% vs its 200-day average ($85.15).
- 52-week range $72.30–$96.29; today's close sits at 56% of that range, 10.9% below the 52-week high.
Oct 6, 2026 — EW dips 0.9% to $86.48
- Closed at $86.48, -0.86% vs the prior close of $87.23. Day range $85.94–$87.88, opened at $87.54.
- Volume was 3.38M shares, 1.0x its 50-day average of 3.39M.
- Price is -2.4% vs its 50-day average ($88.64) and +1.6% vs its 200-day average ($85.15).
- 52-week range $72.30–$96.29; today's close sits at 59% of that range, 10.2% below the 52-week high.
Oct 5, 2026 — EW rises 2.4% to $87.23
- Closed at $87.23, +2.44% vs the prior close of $85.15. Day range $85.34–$87.57, opened at $85.64.
- Volume was 3.32M shares, 0.9x its 50-day average of 3.53M.
- Price is -1.5% vs its 50-day average ($88.57) and +2.5% vs its 200-day average ($85.14).
- 52-week range $72.30–$96.29; today's close sits at 62% of that range, 9.4% below the 52-week high.
Oct 2, 2026 — EW ends flat (-0.0%) to $85.15, 3 down days in a row
- Closed at $85.15, -0.05% vs the prior close of $85.19. Day range $84.66–$86.48, opened at $85.52.
- Volume was 2.41M shares, 0.7x its 50-day average of 3.63M.
- Price is -3.8% vs its 50-day average ($88.48) and +0.0% vs its 200-day average ($85.13).
- 52-week range $72.30–$96.29; today's close sits at 54% of that range, 11.6% below the 52-week high.
- That makes 3 straight losses.
Things to know before you trade EW
- Last results release: Jul 23, 2026 (8-K Item 2.02). Previous ones: Apr 23, 2026, Feb 10, 2026, Oct 30, 2025. Based on that rhythm, the next report is likely around Oct 22, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.16% (largest 2.4%).
- Liquidity: about 3.78M shares (≈$332.71M) trade per day on average.
- 52-week position: $88.10 vs a range of $72.40–$96.29 (66% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Daniel J. Lippis sold 619 shares on Sep 11, 2026.
- Latest filings: 8-K Aug 28, 2026; 10-Q Aug 4, 2026; 8-K Jul 23, 2026.
- Share count: 576.40M shares outstanding (Jul 31, 2026), -1.8% vs a year earlier.
- Listing: NYSE · industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies.
EW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 86.62 | 88.41 | 85.54 | 88.10 | 4.68M |
| Oct 14, 2026 | 85.47 | 86.62 | 84.83 | 86.45 | 4.04M |
| Oct 13, 2026 | 86.55 | 86.77 | 85.07 | 85.27 | 3.64M |
| Oct 12, 2026 | 85.24 | 86.41 | 84.55 | 86.39 | 3.32M |
| Oct 9, 2026 | 84.60 | 85.34 | 83.22 | 85.21 | 3.89M |
| Oct 8, 2026 | 85.65 | 85.78 | 82.43 | 84.24 | 6.52M |
| Oct 7, 2026 | 86.65 | 87.30 | 85.49 | 85.78 | 3.51M |
| Oct 6, 2026 | 87.54 | 87.88 | 85.94 | 86.48 | 3.38M |
| Oct 5, 2026 | 85.64 | 87.57 | 85.34 | 87.23 | 3.32M |
| Oct 2, 2026 | 85.52 | 86.48 | 84.66 | 85.15 | 2.41M |
| Oct 1, 2026 | 85.99 | 86.84 | 84.49 | 85.19 | 3.08M |
| Sep 30, 2026 | 87.16 | 87.49 | 85.72 | 86.32 | 4.89M |
| Sep 29, 2026 | 85.70 | 88.19 | 85.70 | 88.08 | 3.38M |
| Sep 28, 2026 | 86.00 | 87.33 | 85.56 | 86.83 | 3.23M |
| Sep 25, 2026 | 86.66 | 87.11 | 84.93 | 86.29 | 3.60M |
| Sep 24, 2026 | 86.54 | 87.12 | 85.63 | 85.73 | 3.87M |
| Sep 23, 2026 | 88.70 | 88.79 | 86.06 | 86.82 | 3.62M |
| Sep 22, 2026 | 89.00 | 89.66 | 88.50 | 88.78 | 3.53M |
| Sep 21, 2026 | 88.34 | 88.59 | 87.77 | 88.34 | 3.35M |
| Sep 18, 2026 | 88.03 | 88.77 | 87.47 | 88.26 | 4.25M |
About Edwards Lifesciences
Edwards Lifesciences (EW) is listed on the NYSE and classified by the SEC under “Orthopedic, Prosthetic & Surgical Appliances & Supplies”. Its business address is in IRVINE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1099800.
EW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Leslie C. Davis | Director | May 8, 2026 |
| David T Feinberg | Director | May 8, 2026 |
| Kieran Gallahue | Director | May 8, 2026 |
| Paul A Laviolette | Director | May 8, 2026 |
| Steven R Loranger | Director | May 8, 2026 |
| Heisz Leslie Stone | Director | May 8, 2026 |
| Ramona Sequeira | Director | May 8, 2026 |
| Nicholas J Valeriani | Director | May 8, 2026 |
| Bernard J Zovighian | CEO | Jul 27, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Donald E Jr Bobo | CVP,Strategy/Corp Development | May 27, 2026 |
| Annette Bruls | CVP, EMEACLA | Aug 28, 2026 |
| Daveen Chopra | CVP, TMTT, Surgical & IHFM | Sep 11, 2026 |
| Andrew M. Dahl | SVP, Corporate Controller | Sep 14, 2026 |
| Daniel J. Lippis | CVP, TAVR | Sep 11, 2026 |
| Wayne Markowitz | CVP, JAPAC | Sep 14, 2026 |
| Theodora Mistras | CVP, Chief Financial Officer | Jul 10, 2026 |
| Scott B. Ullem | CVP, Chief Financial Officer | May 11, 2026 |
| Bernard J Zovighian | CEO | Jul 27, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Daniel J. Lippis | Sale | 619 | $87.51 |
| Aug 31, 2026 | Andrew M. Dahl | Sale | 544 | $91.06 |
| Aug 28, 2026 | Annette Bruls | Sale | 2,644 | $89.98 |
| Aug 26, 2026 | Wayne Markowitz | Sale | 1,240 | $91.47 |
| Aug 26, 2026 | Daveen Chopra | Sale | 30,646 | $90.99 |
| Aug 26, 2026 | Daveen Chopra | Sale | 1,154 | $91.76 |
| Aug 11, 2026 | Daniel J. Lippis | Sale | 619 | $92.03 |
| Jul 30, 2026 | Wayne Markowitz | Sale | 146 | $86.03 |
| Jul 28, 2026 | Wayne Markowitz | Sale | 9,628 | $85.06 |
| Jul 27, 2026 | Bernard J Zovighian | Sale | 2,921 | $83.93 |
| Jul 10, 2026 | Daniel J. Lippis | Sale | 619 | $91.70 |
| Jun 30, 2026 | Daniel J. Lippis | Sale | 619 | $91.40 |
| Jun 17, 2026 | Bernard J Zovighian | Sale | 523 | $87.92 |
| May 29, 2026 | Andrew M. Dahl | Sale | 568 | $86.08 |
| May 27, 2026 | Donald E Jr Bobo | Sale | 23,145 | $86.42 |
EW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $6.07B | $1.07B | 1.83 | $1.60B |
| Dec 31, 2024 | $5.44B | $4.17B | 6.97 | $542.30M |
| Dec 31, 2023 | $5.01B | $1.40B | 2.30 | $895.80M |
| Dec 31, 2022 | $4.46B | $1.52B | 2.44 | $1.22B |
| Dec 31, 2021 | $5.23B | $1.50B | 2.38 | $1.73B |
Latest balance sheet: total assets $13.87B, total liabilities $3.14B, cash $2.91B (as of Jun 30, 2026).
EW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 23, 2026 | 8-K Item 2.02 (results) | $83.82 |
| Apr 23, 2026 | 8-K Item 2.02 (results) | $79.72 |
| Feb 10, 2026 | 8-K Item 2.02 (results) | $77.05 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $83.48 |
| Jul 24, 2025 | 8-K Item 2.02 (results) | $75.80 |
| Apr 23, 2025 | 8-K Item 2.02 (results) | $70.46 |
| Feb 11, 2025 | 8-K Item 2.02 (results) | $70.91 |
| Oct 24, 2024 | 8-K Item 2.02 (results) | $70.35 |
| Jul 24, 2024 | 8-K Item 2.02 (results) | — |
| Apr 25, 2024 | 8-K Item 2.02 (results) | — |
| Feb 6, 2024 | 8-K Item 2.02 (results) | — |
| Oct 25, 2023 | 8-K Item 2.02 (results) | — |
More on EW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.